Cargando…
Immune checkpoint inhibitor-associated myopathy: a clinicoseropathologically distinct myopathy
Immune checkpoint inhibitors have revolutionized the landscape of cancer treatment. Alongside their many advantages, they elicit immune-related adverse events, including myopathy, which potentially result in substantial morbidity if not recognized and treated promptly. Current knowledge of immune ch...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713997/ https://www.ncbi.nlm.nih.gov/pubmed/33305263 http://dx.doi.org/10.1093/braincomms/fcaa181 |